a meta-analysis showed that the pooled sensitivity and specificity of PSMA PET/CT for detection of RCC local lesions were 87.2%, 100% and metastatic disease were 92%, 96.9% (15). This evidence concerns the gene FOLH1 and metastatic neoplasm.